Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
Phase of Trial: Phase III
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Pitavastatin (Primary)
- Indications Dyslipidaemias; Hyperlipidaemia
- Focus Registrational; Therapeutic Use
- Sponsors Kowa Research Institute
- 07 Jun 2016 Status changed from withdrawn prior to enrolment to discontinued.
- 06 Jun 2016 Status changed from recruiting to withdrawn prior to enrolment.
- 15 Feb 2016 New trial record